Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc's infection-fighting treatment, Neulasta, at a 33 percent discount.



Latest News

CTV News: Woman struck and injured during Montreal police chase

CTV News: Ontario PCs adopt resolution calling 'gender identity theory' a ‘liberal ideology’

WashingtonPost: Thank goodness for the U.S. judiciary

CBS: Trump visits areas affected by California wildfires

CBC: U.S. delegation to address media at Halifax International Security Forum LIVE

BBC: Samuel McKinley: Convicted murderer flees custody again

BBC: Ruthless Djokovic joins Zverev in ATP final

ABC: Charles Howell III clings to 1-shot lead at Sea Island

USA Today: Harvard beats Yale 45-27 at Fenway Park in 135th meeting

USA Today: Holy Cross comes back from 26-point deficit, wins by 1

USA Today: Thompson leads LPGA finale, Jutanugarn eyes more trophies

USA Today: Sebree's career day leads FAU over Towson 85-71

Daily Mail: The world's best wellness escapes revealed

Reuters: UK's Ineos in talks to buy Conoco N.Sea assets - Sunday Times

Los Angeles Times: USC turns blocked punt into touchdown to take lead over UCLA

USA Today: Dorsey's 95-yard KO return closes Rhode Island season 24-21

USA Today: Thompson leads LPGA finale, Jutanugarn eyes more trophies

USA Today: Disney details new 'Star Wars: Galaxy's Edge' attractions, including music by John Williams

FOX: Greece: Police, anarchists mark 1973 uprising with clashes

BBC: Continental Cup: Belfast Giants through to Super Final despite defeat against Katowice

Daily Mail: JEFF PRESTRIDGE: Tighten your belts... and pray we don't get Corbyn! 

Daily Mail: Crispin Odey is caught short by his hedge fund buddies as they bet on Plus500's shares spiralling 

Daily Mail: BA sues U.S. outsourcing giant CBRE over its computer chaos

17 Related Articles from 2018-11-08